Personal Information
Entreprise/Lieu de travail
Livorno Area, Italy Italy
Profession
Direttore S.C. Medicina Generale presso Azienda USL Toscana Nord Ovest
Secteur d’activité
Medical / Health Care / Pharmaceuticals
Mots-clés
comorbidities
renal failure
frailty
padua risk score
venous thromboembolism
fondaparinux
prophylaxis
improve risk score
atrial fibrillation
prevenzione
embolia polmonare
linee guida
anticoagulanti
preserved ejection fraction
frazione di eiezione conservata
scompenso cardiaco
osas
copd
anemia
diabetes
obesity
exercise training
therapy
hfref
hfpef
heart failure
qaly
economic burden
chronic heart failure
chf
life expectancy
milrinone
dopamine
ahf
clinical profiling
diuretics
acute heart failure
enoximone
inotropic agents
phosphodiesterase iii inhibitors
dobutamine
european society of cardiology
first line
peripheral hypoperfusion
furosemide
levosimendan
pharmacotherapy
pharmacological treatment
vasodilator
congestion
esc
basal insulin and glp-1 ras combinations
stress hyperglycemia
acutely ill diabetic patients
glulisine
glargine u300
detemir
glargine
glycemic targets
degludec
yale protocol
lispro
new insulin analogues
hospitalised patients
low molecular weight heparin
practice guidelines
older patients
pulmonary embolism
elba island
risk management
dvt deep vein thrombosis
tuscany
lmwh
tachicardia
arrhythmias
hypothyroidism
heart attack
bradicardia
cardiovascular risk
subclinical
overt
hyperthyroidism
thrombi
transoesophageus
acute stroke
echocardiography
clots
transthoracic
dipiridamolo
rischio emorragico
ictus
aspirina
clopidogrel
stroke
trombolisi
Tout plus
Présentations
(12)J’aime
(1)Linee guida per la fibrillazione atriale
MerqurioEditore_redazione
•
il y a 11 ans
Personal Information
Entreprise/Lieu de travail
Livorno Area, Italy Italy
Profession
Direttore S.C. Medicina Generale presso Azienda USL Toscana Nord Ovest
Secteur d’activité
Medical / Health Care / Pharmaceuticals
Mots-clés
comorbidities
renal failure
frailty
padua risk score
venous thromboembolism
fondaparinux
prophylaxis
improve risk score
atrial fibrillation
prevenzione
embolia polmonare
linee guida
anticoagulanti
preserved ejection fraction
frazione di eiezione conservata
scompenso cardiaco
osas
copd
anemia
diabetes
obesity
exercise training
therapy
hfref
hfpef
heart failure
qaly
economic burden
chronic heart failure
chf
life expectancy
milrinone
dopamine
ahf
clinical profiling
diuretics
acute heart failure
enoximone
inotropic agents
phosphodiesterase iii inhibitors
dobutamine
european society of cardiology
first line
peripheral hypoperfusion
furosemide
levosimendan
pharmacotherapy
pharmacological treatment
vasodilator
congestion
esc
basal insulin and glp-1 ras combinations
stress hyperglycemia
acutely ill diabetic patients
glulisine
glargine u300
detemir
glargine
glycemic targets
degludec
yale protocol
lispro
new insulin analogues
hospitalised patients
low molecular weight heparin
practice guidelines
older patients
pulmonary embolism
elba island
risk management
dvt deep vein thrombosis
tuscany
lmwh
tachicardia
arrhythmias
hypothyroidism
heart attack
bradicardia
cardiovascular risk
subclinical
overt
hyperthyroidism
thrombi
transoesophageus
acute stroke
echocardiography
clots
transthoracic
dipiridamolo
rischio emorragico
ictus
aspirina
clopidogrel
stroke
trombolisi
Tout plus